抗体与药物联合体:针对精确癌症治疗的当前挑战和创新解决方案
Xingyu Zhou1, Yanjie Han1, Yuan Fang1
1Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Med (New York, N.Y.)
|October 1, 2025
概括
抗体-药物联体 (ADC) 提供向癌症治疗,但面临有效性和安全性挑战. 优化ADC设计,链接器化学和有效载荷策略,同时解决交付障碍,对于推进精确瘤学至关重要.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体-药物合物 (ADC) 代表了癌症治疗的重大进步,将抗体引导向与强大的细胞毒剂合并在一起.
- 抗药剂的临床应用在有效性和安全性方面遇到了局限性,需要对其开发和应用有更深入的了解.
研究的目的:
- 审查抗体-药物联合体 (ADC) 开发中的关键问题.
- 探索优化策略,以提高ADC在癌症治疗中的有效性和安全性.
- 讨论ADC技术的新兴趋势和未来方向.
主要方法:
- 对当前ADC开发,链接器化学和有效载荷策略的文献综述.
- 分析目标抗原表达与临床反应之间的关系.
- 评估改善ADC分配和有效载荷释放的战略.
主要成果:
- 重新评估传统的链接器设计原则,有利于瘤微环境响应释放.
- 探索新的有效载荷策略,包括免疫刺激ADCs (ISACs) 和降解剂-抗体合物 (DACs).
- 确定瘤传递障碍和临床前临床差距作为关键挑战.
结论:
- 推进ADC治疗需要超越结构复杂性,以应对瘤输送和有效载荷释放的根本挑战.
- 优化链接器稳定性,有效载荷类型和抗体向对于改善临床结果至关重要.
- 弥合临床前发现和临床应用之间的差距对于实现ADC在精密瘤学中的全部潜力至关重要.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
01:30Cancer Vaccines
972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972